Financhill
Back

Apellis Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
47

APLS
Apellis Pharmaceuticals

Last Price:
29.28
Seasonality Move:
20.78%
Buy
60

BMRN
Biomarin Pharmaceutical

Last Price:
66.13
Seasonality Move:
13.04%
Sell
47
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $29.26. The Score for APLS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $66.12. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $29.26
    The current trend is relatively stagnant and APLS is experiencing slight buying pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $66.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight selling pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 52.74 Buy
Chaikin Money Flow: 179519 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.95 - 28.71) Buy
Bollinger Bands (100): (29.49 - 39.35) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.69 Sell
Relative Strength Index (14 RSI): 33.22 Sell
Chaikin Money Flow: -314047 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.74 - 70.42) Sell
Bollinger Bands (100): (70.34 - 87.98) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.88 Buy
20-day SMA: 28.02 Buy
50-day SMA: 30.86 Sell
200-day SMA: 43.85 Sell
8-day EMA: 28.92 Buy
20-day EMA: 28.61 Buy
50-day EMA: 30.58 Sell
200-day EMA: 40.41 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.41 Sell
20-day SMA: 68.28 Sell
50-day SMA: 72.14 Sell
200-day SMA: 82.07 Sell
8-day EMA: 66.71 Sell
20-day EMA: 68.01 Sell
50-day EMA: 72.04 Sell
200-day EMA: 80.69 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):